Roche’s Susvimo Receives Positive CHMP Opinion for EU Approval
BASEL, Switzerland, July 24, 2026 Roche announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use...
European Commission
Advertisement
Kyowa Kirin Wins EC Approval for Crysvita in Infants
GALASHIELS & MARLOW, United Kingdom, July 21, 2026 Kyowa Kirin EMEA has announced that the European Commission (EC) has...
Allergan Aesthetics Wins EU Approval for Boey Neurotoxin
NORTH CHICAGO, Ill., July 17, 2026 Allergan Aesthetics, an AbbVie company, announced that the European Commission has approved Boey®...
Vanda Gains EMA Orphan Status for Imsidolimab in GPP
WASHINGTON, July 16, 2026 Vanda Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) at the European...
Boehringer Ingelheim Wins EU Approval for JASCAYD
INGELHEIM, Germany, July 17, 2026 Boehringer Ingelheim has announced that the European Commission (EC) has granted marketing authorization for...
Advertisements
Novo Nordisk Secures EU Approval for Oral Wegovy
BAGSVÆRD, Denmark, July 15, 2026 Novo Nordisk has achieved a major regulatory milestone after the European Commission (EC) granted...
Montefiore Einstein Expands CGM Use to Improve Diabetes Care
BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...
AMO Pharma Aligns Global Trial Plan for AMO-02 in cDM1
LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...
AbbVie Wins EU Approval for TEPKINLY in Follicular Lymphoma
NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...
Genmab Wins EU Approval for TEPKINLY Plus R2
COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...
Advertisement
